 Evan Carey
Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumonia, Ventilator-Associated | 4 | 2023 | 53 | 2.340 |
Why?
| | Veterans | 13 | 2024 | 1476 | 2.230 |
Why?
| | Pneumonia | 3 | 2023 | 639 | 1.480 |
Why?
| | Pain Management | 4 | 2019 | 352 | 1.050 |
Why?
| | United States Department of Veterans Affairs | 13 | 2024 | 678 | 1.020 |
Why?
| | Veterans Health | 6 | 2024 | 186 | 0.990 |
Why?
| | Chronic Pain | 5 | 2024 | 262 | 0.990 |
Why?
| | Cross Infection | 2 | 2021 | 256 | 0.740 |
Why?
| | Kidney Diseases | 1 | 2022 | 408 | 0.570 |
Why?
| | Health Services Accessibility | 4 | 2018 | 986 | 0.500 |
Why?
| | Depression | 3 | 2021 | 1397 | 0.490 |
Why?
| | Telemedicine | 4 | 2022 | 862 | 0.480 |
Why?
| | Sepsis | 1 | 2022 | 617 | 0.480 |
Why?
| | Percutaneous Coronary Intervention | 5 | 2022 | 480 | 0.460 |
Why?
| | Oropharyngeal Neoplasms | 2 | 2025 | 63 | 0.420 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 1040 | 0.400 |
Why?
| | Papillomavirus Infections | 2 | 2025 | 325 | 0.320 |
Why?
| | United States | 18 | 2024 | 14841 | 0.300 |
Why?
| | Hospitals, Veterans | 4 | 2018 | 252 | 0.290 |
Why?
| | Medication Adherence | 3 | 2015 | 467 | 0.240 |
Why?
| | Delivery of Health Care | 2 | 2024 | 951 | 0.240 |
Why?
| | Pandemics | 3 | 2024 | 1639 | 0.230 |
Why?
| | Humans | 34 | 2025 | 137585 | 0.230 |
Why?
| | Risk Factors | 5 | 2023 | 10388 | 0.230 |
Why?
| | beta-Alanine | 2 | 2015 | 16 | 0.230 |
Why?
| | Papillomaviridae | 1 | 2025 | 125 | 0.220 |
Why?
| | Antithrombins | 2 | 2015 | 60 | 0.220 |
Why?
| | Patient Education as Topic | 4 | 2018 | 766 | 0.210 |
Why?
| | Myocardial Infarction | 4 | 2016 | 1046 | 0.210 |
Why?
| | Benzimidazoles | 2 | 2015 | 170 | 0.210 |
Why?
| | DNA, Viral | 1 | 2025 | 364 | 0.200 |
Why?
| | Retrospective Studies | 10 | 2024 | 15657 | 0.200 |
Why?
| | Courage | 1 | 2022 | 3 | 0.200 |
Why?
| | Natural Language Processing | 1 | 2023 | 95 | 0.190 |
Why?
| | Quality Assurance, Health Care | 1 | 2023 | 322 | 0.180 |
Why?
| | Physician-Patient Relations | 2 | 2018 | 548 | 0.180 |
Why?
| | Erythrocyte Transfusion | 1 | 2023 | 194 | 0.180 |
Why?
| | Myocardial Ischemia | 1 | 2022 | 263 | 0.170 |
Why?
| | Community Health Services | 2 | 2019 | 227 | 0.170 |
Why?
| | Prospective Studies | 6 | 2025 | 7604 | 0.160 |
Why?
| | Acute Coronary Syndrome | 2 | 2014 | 279 | 0.160 |
Why?
| | Aged | 13 | 2025 | 23961 | 0.160 |
Why?
| | Bronchodilator Agents | 1 | 2021 | 252 | 0.150 |
Why?
| | Administration, Inhalation | 1 | 2021 | 688 | 0.150 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2025 | 1079 | 0.150 |
Why?
| | Patient-Centered Care | 2 | 2015 | 530 | 0.150 |
Why?
| | Polysomnography | 1 | 2019 | 185 | 0.150 |
Why?
| | Vitamin D | 1 | 2022 | 397 | 0.140 |
Why?
| | Thyroid Neoplasms | 1 | 2022 | 343 | 0.140 |
Why?
| | Middle Aged | 15 | 2025 | 33479 | 0.140 |
Why?
| | Comorbidity | 3 | 2018 | 1622 | 0.140 |
Why?
| | Biomarkers, Tumor | 1 | 2025 | 1276 | 0.140 |
Why?
| | Myocardial Revascularization | 1 | 2018 | 73 | 0.140 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 606 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 1 | 2021 | 565 | 0.130 |
Why?
| | Prasugrel Hydrochloride | 1 | 2016 | 22 | 0.130 |
Why?
| | Patient Discharge | 2 | 2014 | 897 | 0.130 |
Why?
| | Ovarian Neoplasms | 1 | 2022 | 565 | 0.130 |
Why?
| | Spatial Analysis | 1 | 2016 | 20 | 0.120 |
Why?
| | Coronary Artery Bypass | 1 | 2018 | 234 | 0.120 |
Why?
| | Self Care | 2 | 2018 | 380 | 0.120 |
Why?
| | Sleep Wake Disorders | 1 | 2019 | 286 | 0.120 |
Why?
| | Substance-Related Disorders | 1 | 2024 | 1083 | 0.120 |
Why?
| | Electronic Health Records | 1 | 2023 | 1069 | 0.120 |
Why?
| | Remote Consultation | 1 | 2015 | 54 | 0.120 |
Why?
| | Qualitative Research | 1 | 2022 | 1386 | 0.110 |
Why?
| | Specialties, Surgical | 1 | 2015 | 75 | 0.110 |
Why?
| | Cardiac Care Facilities | 1 | 2014 | 13 | 0.110 |
Why?
| | Early Medical Intervention | 1 | 2015 | 57 | 0.110 |
Why?
| | Incidence | 1 | 2021 | 2804 | 0.110 |
Why?
| | Medicine | 1 | 2015 | 121 | 0.110 |
Why?
| | Primary Health Care | 1 | 2024 | 1738 | 0.110 |
Why?
| | Health Status | 2 | 2016 | 792 | 0.110 |
Why?
| | Hospitals | 2 | 2021 | 691 | 0.110 |
Why?
| | Analgesics, Opioid | 2 | 2020 | 1000 | 0.100 |
Why?
| | Drug Monitoring | 1 | 2015 | 218 | 0.100 |
Why?
| | Anxiety | 1 | 2021 | 1035 | 0.100 |
Why?
| | Atrial Fibrillation | 2 | 2015 | 388 | 0.100 |
Why?
| | Cardiotonic Agents | 1 | 2014 | 124 | 0.100 |
Why?
| | Cost of Illness | 1 | 2015 | 308 | 0.100 |
Why?
| | Cohort Studies | 6 | 2024 | 5742 | 0.100 |
Why?
| | Patient Care Team | 2 | 2015 | 631 | 0.100 |
Why?
| | Secondary Prevention | 1 | 2014 | 233 | 0.100 |
Why?
| | Female | 14 | 2025 | 73304 | 0.100 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2016 | 463 | 0.100 |
Why?
| | Male | 13 | 2025 | 67762 | 0.100 |
Why?
| | Heart Failure | 2 | 2016 | 2236 | 0.090 |
Why?
| | Quality Indicators, Health Care | 1 | 2014 | 307 | 0.090 |
Why?
| | Health Services Needs and Demand | 1 | 2013 | 273 | 0.090 |
Why?
| | Heart Diseases | 1 | 2014 | 346 | 0.090 |
Why?
| | Patient Selection | 1 | 2015 | 696 | 0.090 |
Why?
| | Cardiac Catheterization | 1 | 2014 | 530 | 0.090 |
Why?
| | Cardiovascular Agents | 1 | 2012 | 159 | 0.090 |
Why?
| | Hospitalization | 3 | 2022 | 2199 | 0.090 |
Why?
| | Thrombosis | 1 | 2014 | 371 | 0.080 |
Why?
| | Stents | 1 | 2014 | 527 | 0.080 |
Why?
| | Adult | 7 | 2025 | 37929 | 0.080 |
Why?
| | Longitudinal Studies | 4 | 2022 | 2844 | 0.080 |
Why?
| | Coronary Artery Disease | 1 | 2014 | 698 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 1 | 2016 | 1313 | 0.070 |
Why?
| | Registries | 1 | 2014 | 2035 | 0.060 |
Why?
| | Travel | 2 | 2018 | 130 | 0.060 |
Why?
| | Research Design | 1 | 2012 | 1139 | 0.060 |
Why?
| | Patient Reported Outcome Measures | 2 | 2022 | 402 | 0.060 |
Why?
| | Stroke | 1 | 2014 | 1120 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2025 | 5131 | 0.060 |
Why?
| | Dabigatran | 2 | 2015 | 22 | 0.060 |
Why?
| | Risk Assessment | 1 | 2014 | 3457 | 0.060 |
Why?
| | Asthma | 1 | 2018 | 2295 | 0.060 |
Why?
| | Time Factors | 4 | 2016 | 6828 | 0.050 |
Why?
| | Technology | 1 | 2024 | 96 | 0.050 |
Why?
| | Quality of Life | 1 | 2015 | 2892 | 0.050 |
Why?
| | Ethics Committees, Research | 1 | 2023 | 42 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1910 | 0.050 |
Why?
| | Interdisciplinary Communication | 2 | 2015 | 191 | 0.050 |
Why?
| | Treatment Outcome | 4 | 2022 | 10811 | 0.050 |
Why?
| | Postoperative Complications | 1 | 2014 | 2654 | 0.050 |
Why?
| | Platinum | 1 | 2022 | 50 | 0.050 |
Why?
| | Carboplatin | 1 | 2022 | 144 | 0.050 |
Why?
| | Minority Groups | 1 | 2024 | 266 | 0.050 |
Why?
| | Multivariate Analysis | 2 | 2016 | 1509 | 0.040 |
Why?
| | Hemorrhage | 2 | 2016 | 722 | 0.040 |
Why?
| | Coronary Angiography | 1 | 2022 | 317 | 0.040 |
Why?
| | Artificial Intelligence | 1 | 2023 | 279 | 0.040 |
Why?
| | Early Detection of Cancer | 1 | 2025 | 447 | 0.040 |
Why?
| | Patient Readmission | 2 | 2018 | 697 | 0.040 |
Why?
| | Aged, 80 and over | 2 | 2025 | 7635 | 0.040 |
Why?
| | Complementary Therapies | 1 | 2019 | 88 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5472 | 0.040 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2019 | 125 | 0.030 |
Why?
| | Communication | 1 | 2024 | 879 | 0.030 |
Why?
| | Erythrocytes | 1 | 2023 | 700 | 0.030 |
Why?
| | Occupational Therapy | 1 | 2019 | 100 | 0.030 |
Why?
| | Costs and Cost Analysis | 1 | 2018 | 213 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2023 | 1477 | 0.030 |
Why?
| | Coronary Thrombosis | 1 | 2016 | 25 | 0.030 |
Why?
| | Elective Surgical Procedures | 1 | 2018 | 179 | 0.030 |
Why?
| | Drug Utilization Review | 1 | 2016 | 57 | 0.030 |
Why?
| | Off-Label Use | 1 | 2016 | 52 | 0.030 |
Why?
| | Hypesthesia | 1 | 2016 | 17 | 0.030 |
Why?
| | Physical Therapy Modalities | 1 | 2019 | 308 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1459 | 0.030 |
Why?
| | Mental Health | 1 | 2022 | 726 | 0.030 |
Why?
| | Chest Pain | 1 | 2016 | 91 | 0.030 |
Why?
| | Cost Savings | 1 | 2015 | 84 | 0.030 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2015 | 82 | 0.030 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2014 | 69 | 0.030 |
Why?
| | Prosthesis Failure | 1 | 2014 | 123 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2018 | 642 | 0.020 |
Why?
| | Medication Reconciliation | 1 | 2012 | 29 | 0.020 |
Why?
| | Pharmacists | 1 | 2015 | 265 | 0.020 |
Why?
| | Community Pharmacy Services | 1 | 2012 | 45 | 0.020 |
Why?
| | Disease Management | 1 | 2016 | 628 | 0.020 |
Why?
| | Interprofessional Relations | 1 | 2014 | 283 | 0.020 |
Why?
| | Databases, Factual | 1 | 2016 | 1357 | 0.020 |
Why?
| | Reminder Systems | 1 | 2012 | 169 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 591 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2012 | 451 | 0.020 |
Why?
| | Prevalence | 1 | 2016 | 2734 | 0.020 |
Why?
| | Health Care Costs | 1 | 2012 | 398 | 0.020 |
Why?
| | Prognosis | 1 | 2014 | 4030 | 0.010 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2012 | 1329 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2016 | 5778 | 0.010 |
Why?
|
|
Carey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|